THIRD ROCK VENTURES
Third Rock Ventures invests in transformational life science companies that show high growth potential and are well-positioned to make a difference in the marketplace.
THIRD ROCK VENTURES
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
2007-01-01
Status:
Active
Contact:
(415) 766-3600
Email Addresses:
[email protected]
Technology used in webpage:
Google Tag Manager Google Universal Analytics Domain Not Resolving Global Site Tag Cloudflare Cloudflare Hosting COVID-19 ASP.NET IIS Pound Sterling
Similar Organizations
Blue Belt Technologies
Blue Belt Technologies is a medical device company that focuses on technology and capabilities of surgical instrumentation.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Polaris Partners
Polaris Partners invests in healthcare and technology companies ​across all stages from founding to profitable growth.
Rittenhouse Ventures
Rittenhouse Ventures invests in small rounds of capital-efficient Early-Growth stage companies primarily in Healthcare and Pharma IT.
Thar Pharmaceuticals
Thar Pharmaceuticals identifies and develops prescription drugs that solve clinical opportunities such as efficacy, absorption and safety.
Xip
Xip produces disposable blood analyzers that wirelessly upload lab-quality clinical measurements in minutes.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-25 | Terremoto Biosciences | Third Rock Ventures investment in Series A - Terremoto Biosciences | 75 M USD |
| 2022-05-10 | MOMA Therapeutics | Third Rock Ventures investment in Series B - MOMA Therapeutics | 150 M USD |
| 2022-03-24 | Celsius Therapeutics | Third Rock Ventures investment in Series B - Celsius Therapeutics | 83 M USD |
| 2022-01-27 | Septerna | Third Rock Ventures investment in Series A - Septerna | 100 M USD |
| 2021-12-21 | Ambys Medicines | Third Rock Ventures investment in Series A - Ambys Medicines | 47 M USD |
| 2021-10-25 | Cedilla Therapeutics | Third Rock Ventures investment in Series B - Cedilla Therapeutics | 25 M USD |
| 2021-09-01 | Asher Bio | Third Rock Ventures investment in Series B - Asher Bio | 108 M USD |
| 2021-06-23 | Abata Therapeutics | Third Rock Ventures investment in Series A - Abata Therapeutics | 95 M USD |
| 2021-05-13 | Flare Therapeutics | Third Rock Ventures investment in Series A - Flare Therapeutics | 82 M USD |
| 2021-03-23 | Asher Bio | Third Rock Ventures investment in Series A - Asher Bio | 55 M USD |